Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06582914 · ClinicalTrials.gov registry record
Lynch Syndrome Integrative Epidemiology and Genetics
A clinical trial of Lynch Syndrome, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 2
- Study locations
NCT06582914: Recruiting study of Lynch Syndrome, sponsored by University of Colorado, Denver.
NCT06582914 is a study of Lynch Syndrome that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 5,000 participants, above the 2,078-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (141% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06582914, a study of Lynch Syndrome, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The vision of the "Lynch syndrome INtegrative Epidemiology And GEnetics" (LINEAGE) Consortium is to collaboratively improve the lives and longevity of individuals and families with Lynch syndrome. The mission of the LINEAGE Consortium is to collaboratively improve Lynch syndrome care through high-quality research. This consortium will provide intellectual and infrastructure support to facilitate development of research questions, collection of standardized data and biospecimens, support of grant applications, and generation of collaborative manuscripts. Our aims are to: I. Establish a prospective cohort of individuals with Lynch syndrome II. Collect standardized longitudinal clinical and biosample data to elucidate Lynch Syndrome epidemiology and gene-host interactions III. Promote intervention trials to improve cancer prevention and early detection in Lynch Syndrome
Primary Outcome
cases of adenocarcinoma of the colon or rectum diagnosed over the observation period
Conditions Studied
Study Locations (2)
Colorado
- University of Colorado - Aurora
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2054-12-31 |
What NCT06582914 shows while recruiting
NCT06582914 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,078-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (141% higher).
The record links to 1 condition, with Lynch Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT06582914 reports a single indexed study location in Colorado, Illinois.
Frequently Asked Questions
What is clinical trial NCT06582914 about?
NCT06582914 is a clinical study titled "Lynch Syndrome Integrative Epidemiology and Genetics". The vision of the "Lynch syndrome INtegrative Epidemiology And GEnetics" (LINEAGE) Consortium is to collaboratively improve the lives and longevity of individuals and families with Lynch syndrome. The mission of the LINEAGE Consortium is to collaboratively improve Lynch syndrome care through high-q...
What is the current status of trial NCT06582914?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2024-10-01. Estimated completion is 2054-12-31.
What conditions does trial NCT06582914 study?
This clinical trial studies the following conditions: Lynch Syndrome.
Who is sponsoring clinical trial NCT06582914?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06582914 being conducted?
This trial has 2 study locations across Colorado, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lynch Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06582914's enrollment target sits among peer trials
5,000 3rd of 21 higher than 19 of 21 other Lynch Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lynch Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Cancer of the Pancreas Screening-5 CAPS5)Study
RECRUITING · Phase 3
-
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
RECRUITING
-
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
RECRUITING
-
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
RECRUITING · Phase 2
-
Identifying and Caring for Individuals With Inherited Cancer Syndrome
RECRUITING · NA
-
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI